Literature DB >> 20705919

Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation.

Jian-Bo Wan1, Li-Li Huang, Rong Rong, Rui Tan, Jingdong Wang, Jing X Kang.   

Abstract

OBJECTIVE: To use the fat-1 transgenic mouse model to determine the role of tissue n-6/n-3 fatty acid ratio in atherosclerotic plaque formation. Although it has been suggested that a low ratio of n-6/n-3 polyunsaturated fatty acids (PUFAs) is more desirable in reducing the risk of atherosclerotic cardiovascular disease, the role of tissue n-6/n-3 fatty acid ratio in atherosclerosis has not been sufficiently tested in a well-controlled experimental system. The fat-1 transgenic mouse model, expressing an n-3 fatty acid desaturase, is capable of producing n-3 PUFAs from n-6 PUFAs and thereby has a ratio of n-6/n-3 fatty acids close to 1:1 in tissues and organs. METHODS AND
RESULTS: To generate apolipoprotein E-deficient plus fat-1 transgenic mice (apoE(-/-)/fat-1), we crossed heterozygous fat-1 mice with apoE(-/-) mice. After 14 weeks of a Western-type diet rich in n-6 PUFAs, the apoE(-/-)/fat-1 mice showed a lower ratio of n-6/n-3 fatty acids than the apoE(-/-) mice in all organs and tissues tested. The aortic lesion area in apoE(-/-)/fat-1 mice was significantly reduced when compared with that of apoE(-/-) littermates (7.14±0.54% versus 13.49±1.61%). There were no differences in plasma cholesterol or high- and low-density lipoprotein levels between the 2 groups, except for a higher triglyceride level in the apoE(-/-)/fat-1 mice. A significant reduction of interleukin 6 and prostaglandin E(2) in both plasma and aorta culture medium was observed in apoE(-/-)/fat-1 mice. RT-PCR analysis also indicated that the expression of intercellular adhesion molecule-1, monocyte chemoattractant protein-1, interleukin 6, and cyclooxygenase-2 was lower in the aortas and the circulating monocytes from apoE(-/-)/fat-1 mice. In addition, the expression of nuclear factor κB/p65 in the aorta and the recruitment of macrophages into atherosclerotic plaques were reduced in apoE(-/-)/fat-1 mice, compared with apoE(-/-) mice.
CONCLUSIONS: To our knowledge, this is the first study to provide direct evidence for the role of tissue n-6/n-3 ratio in atherosclerosis using the fat-1 transgenic mouse model. Our findings demonstrate that a decreased n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apoE(-/-) mice. This protective effect may be attributed to the antiinflammatory properties of n-3 fatty acids, rather than their lipid-lowering effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705919     DOI: 10.1161/ATVBAHA.110.210054

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  39 in total

1.  Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis.

Authors:  Yajin Liu; Xuan Fang; Xu Zhang; Jing Huang; Jinlong He; Liyuan Peng; Chenji Ye; Yingmei Wang; Fengxia Xue; Ding Ai; Dan Li; Yi Zhu
Journal:  Br J Pharmacol       Date:  2017-09-05       Impact factor: 8.739

2.  Eicosapentaenoic acid and docosahexaenoic acid regulate modified LDL uptake and macropinocytosis in human macrophages.

Authors:  James E McLaren; Daryn R Michael; Irina A Guschina; John L Harwood; Dipak P Ramji
Journal:  Lipids       Date:  2011-08-07       Impact factor: 1.880

3.  Ceacam1 deletion causes vascular alterations in large vessels.

Authors:  Sonia M Najjar; Kelly J Ledford; Simon L Abdallah; Alexander Paus; Lucia Russo; Meenakshi K Kaw; Sadeesh K Ramakrishnan; Harrison T Muturi; Christian K Raphael; Sumona Ghosh Lester; Garrett Heinrich; Sandrine V Pierre; Ralf Benndorf; Veronika Kleff; Ayad A Jaffa; Emile Lévy; Guillermo Vazquez; Ira J Goldberg; Nicole Beauchemin; Rosario Scalia; Süleyman Ergün
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-25       Impact factor: 4.310

4.  Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.

Authors:  Amanda L Brown; Xuewei Zhu; Shunxing Rong; Swapnil Shewale; Jeongmin Seo; Elena Boudyguina; Abraham K Gebre; Martha A Alexander-Miller; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-19       Impact factor: 8.311

5.  Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma.

Authors:  Jian-Feng Qiu; Ke-Lin Zhang; Xiao-Jing Zhang; Yuan-Jia Hu; Peng Li; Chang-Zhen Shang; Jian-Bo Wan
Journal:  Lipids       Date:  2015-08-21       Impact factor: 1.880

6.  Pretreatment with n-6 PUFA protects against subsequent high fat diet induced atherosclerosis--potential role of oxidative stress-induced antioxidant defense.

Authors:  M Penumetcha; M Song; N Merchant; S Parthasarathy
Journal:  Atherosclerosis       Date:  2011-10-12       Impact factor: 5.162

7.  Combined Effects of Plant Sterols with Low Ratio of n-6/n-3 Polyunsaturated Fatty Acids against Atherosclerosis in ApoE-/- Mice.

Authors:  Chen Chen; Li Lu; Ya-Ting Qin; Chao Lv; Xiao-Ning Wan; Xiao-Mei Guo
Journal:  Curr Med Sci       Date:  2021-01-11

Review 8.  Inflammation and its resolution as determinants of acute coronary syndromes.

Authors:  Peter Libby; Ira Tabas; Gabrielle Fredman; Edward A Fisher
Journal:  Circ Res       Date:  2014-06-06       Impact factor: 17.367

9.  Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.

Authors:  Chuchun L Chang; Claudia Torrejon; Un Ju Jung; Kristin Graf; Richard J Deckelbaum
Journal:  Atherosclerosis       Date:  2014-04-03       Impact factor: 5.162

10.  The Benefits of Omega-3 Fats for Stabilizing and Remodeling Atherosclerosis.

Authors:  James J DiNicolantonio; James H O'Keefe
Journal:  Mo Med       Date:  2020 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.